Healthcare Services company Dr. Lal Pathlabs announced Q2FY24 results:
1. Financial Performance
- Total revenue of Rs 601 crore in Q2FY24, an increase of 12.6% compared to Q2FY23.
- Revenue excluding RTPCR increased by 14.4% in Q2FY24.
- EBITDA margin for Q2FY24 was 29.6%.
- PBT for Q2FY24 was Rs 152 crore.
- PAT for Q2FY24 was Rs 111 crore.
- PAT margin for Q2FY24 was 18.4%.
- The company's EPS for Q2FY24 was 13.2.
2. Operating Expenditure
- Operating Expenditure for Q2FY24 was Rs 424 crore.
- Operating Expenditure increased by 8.6% compared to Q2FY23.
3. Other Financial Highlights
- Other Income for Q2FY24 was Rs 18 crore.
- Depreciation cost for Q2FY24 was Rs 36 crore.
- Finance cost for Q2FY24 was Rs 8 crore.